Computational Investigation of Plant-based Bioactive Compounds as Inhibitors against Tuberculosis
Keywords:<i>InhA</i>, Liquirtin, <i>Mycobacterium tuberculosis</i>, Molecular Docking, Terflavin B
AbstractThe objective of the work is to identify a natural origin compound that could have an anti-tubercular effect, thereby preventing the infection in humans using computational approach. Our focus was to find a inhibitor for Enoylacyl carrier reductase enzyme and hence chemically diverse scaffolds from plants origin were selected. Admet parameters were performed for the compounds, and the top nine compounds among 50 compounds were found to be non-carcinogenic. The pharmacological predicted activity (Pa) of few compounds such as 14-Deoxy-11,12 didehydroandrographolide, Terflavin B, and Liquirtin was found to be more active when compared with that of the standard reference. Further more the synthesis of these active compounds derivatives can be investigated theoretical followed by its synthesis and evaluation by in vitro activity against the InhA could be of interest.
Zaman K. Tuberculosis: A global health problem. J Health Popul Nutr. 2010; 28(2):111–3. https://doi.org/10.3329/jhpn.v28i2.4879. PMid:20411672. PMCid:PMC2980871
Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, et al. Extrapulmonary tuberculosis: A retrospective review of 194 cases at a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2010; 60(2):105–9. PMID: 20209695.
Sandhu GK. Tuberculosis: Current situation, challenges and overview of its control programs in India. J Glob Infect Dis. 2011; 3(2):143–50. https://doi.org/10.4103/0974- 777X.81691. PMid:21731301. PMCid:PMC3125027
Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberc. 2009; 56(1):30–43.PMID: 19402270.
Smith KC, Armitige L, Wanger A. A review of tuberculosis: Reflections on the past, present and future of a global epidemic disease. Expert Rev Anti Infect Ther. 2003; 1(3):483–91. https://doi.org/10.1586/14787184.108.40.2063. PMid:15482144
Singh MM. XDR-TB--danger ahead. Indian J Tuberc. 2007; 54(1):1–2. PMID: 17455416.
Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, et al. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res. 2010; 131:809–13.PMID: 20571171.
Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Medicine. 2016; 13(10). https://doi.org/10.1371/journal.pmed.1002152. PMid:27780211. PMCid:PMC5079585
Suresh AJ, Nandini S, Sangeetha K, Dhivya LS, Surya PR. Design, synthesis and invitro biological evaluation of pyridine, thiadazole, benzimidazole and acetyl thiophne analogues as anti tubercular agents targeting enzyme InhA. Curr Comput-Aided. 2020. https://doi.org/10.2174/1573409916666200724152827. PMid:32713342
Suresh J, Baek SC, Ramakrishnan SP, Kim H, Mathew B. Discovery of potent and reversible MAO-B inhibitors as furanochalcones. Int J Biol Macromol. 2018; 108:660–4. https://doi.org/10.1016/j.ijbiomac.2017.11.159. PMid:29195801
Sander T, Freyss J, von Korff M, Reich JR, Rufener C. OSIRIS, an entirely in-house developed drug discovery informatics system. J Chem Inf Model. 2009; 49(2):232–46. https://doi.org/10.1021/ci800305f. PMid:19434825
Sabarathinam S, Vijayakumar TM. Assessment of herbdrug interactions based on the pharmacokinetic changes of probe drug, midazolam. Drug Metab Lett. 2021; 14(1):5–8. https://doi.org/10.2174/1872312814666201112122110. PMid:33183217
Sabarathinam S, Vijayakumar TM. A short exploration of selected sensitive CYP3A4 substrates (probe drug). Drug Metab Lett. 2021; 14(1):2–4. https://doi.org/10.2174/18723 12814666200811110024. PMid:32781977
Mittal M, Goel RK, Bhargava G, Mahajan MP. PASS-assisted exploration of antidepressant activity of 1,3,4-trisubstituted- beta-lactam derivatives. Bioorganic Med Chem Lett. 2008; 18(20):5347–9. https://doi.org/10.1016/j.bmcl.2008.09.064. PMid:18835165
Tucker EW, Dooley KE. Preclinical tools for the evaluation of tuberculosis treatment regimens for children. Int J Tuberc Lung Dis. 2018; 22(5):7–14. https://doi.org/10.5588/ijtld.17.0354. PMid:29665948. PMCid: PMC7577428
Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, et al. The war against tuberculosis: A review of natural compounds and their derivatives. Molecules (Basel, Switzerland). 2020; 25(13). https://doi.org/10.3390/molecules25133011. PMid:32630150. PMCid:PMC7412169
Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-Ldrissi M, Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn. 2021; 39(8):2971-9. https://doi.org/10.1080/07391102.2020.1758790. PMid:32306860. PMCid:PMC7212546
Gutierrez-Lugo MT, Bewley CA. Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem. 2008; 51(9):2606–12. https://doi.org/10.1021/ jm070719i. PMid:18393405. PMCid:PMC6260804
Borad MA, Jethava DJ, Bhoi MN, Patel CN, Pandya HA, Patel HD. Novel isoniazid-spirooxindole derivatives: design, synthesis, biological evaluation, in silico ADMET prediction and computational studies. J Mol Struct. 2020; 1222. https://doi.org/10.1016/j.molstruc.2020.128881
Guan L, Yang H, Cai Y, Sun L, Di P, Li W, et al. ADMETscore - a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2018; 10(1):148– 57. https://doi.org/10.1039/C8MD00472B. PMid:30774861. PMCid:PMC6350845